 fda approves cefiderocol for hospital acquired ventilator associated pneumonia fdas approval means that cefiderocol sold under the brand name fetroja can be used to treat patients who have hospital acquired and ventilator associated bacterial pneumonia habp vabp caused by gram negative pathogens the antibiotic was initially approved for treatment of complicated urinary tract infections 